For its fourth fiscal quarter (ending December 31), DexCom Inc (NASDAQ: DXCM) has reported a -42% decline in E.P.S. from $0.67 a year ago to $0.39 in the current quarter. This performance was $-0.11 short […]
Cohu Inc (NASDAQ: COHU) has reported E.P.S. of $-0.46 for its fourth fiscal quarter (ending December 31) versus $-0.04 for the same period a year ago. Relative to the consensus estimate of $-0.09, this was […]
Blueprint Medicines Corp (NASDAQ: BPMC) has reported a loss for its fourth fiscal quarter (ending December 31) of $-0.79 versus a loss $-1.82 for the same period a year ago. Relative to the consensus estimate […]
For its fourth fiscal quarter (ending December 31), Agios Pharmaceuticals Inc (NASDAQ: AGIO) has reported E.P.S. of $-1.69 compared to $-1.72 a year ago. Relative to the consensus estimate of $-1.63, this was a shortfall […]
Yelp Inc (NYSE: YELP) has reported E.P.S. of $0.64 for its fourth fiscal quarter (ending December 31) versus $0.40 for the same period a year ago — an increase of 60%. Relative to the consensus […]
Ultragenyx Pharmaceutical Inc (NASDAQ: RARE) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.39 versus a loss $-1.52 for the same period a year ago. This result fell short of […]
For its first fiscal quarter (ending December 31), Sally Beauty Holdings Inc (NYSE: SBH) has reported a 67% increase in E.P.S. from $0.36 a year ago to $0.60 in the current quarter. This performance was […]
PPL Corp (NYSE: PPL) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.24 versus $0.15 for the same period a year ago — an increase of 60%. However, this result fell […]
For its fourth fiscal quarter (ending December 31), PDF Solutions Inc (NASDAQ: PDFS) has reported a -50% decline in E.P.S. from $0.02 a year ago to $0.01 in the current quarter. This performance was $-0.20 […]
GoDaddy Inc (NYSE: GDDY) has reported E.P.S. of $1.40 for its fourth fiscal quarter (ending December 31) versus $7.88 for the same period a year ago — a decline of -82%. Relative to the consensus […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research